Switch theme
Sign up to access all valuation multiples
Nano X Imaging Ltd is engaged in the business of manufacturing medical imaging systems. It offers a Nanox System which is a combination of hardware and software. It develops a prototype of the Nanox.ARC, a medical imaging system incorporating its novel digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that will allow for the delivery of medical screening as a service. It has three business segments: Nanox.ARC division, the radiology services division and the AI solutions division. Key revenue is generated from Radiology Services.
2018
165
LTM Revenue $12.3M
Last FY EBITDA -$45.0M
$272M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Nano X Imaging has a last 12-month revenue (LTM) of $12.3M and a last 12-month EBITDA of n/a.
In the most recent fiscal year, Nano X Imaging achieved revenue of $11.3M and an EBITDA of -$45.0M.
Nano X Imaging expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Nano X Imaging valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $12.3M | XXX | $11.3M | XXX | XXX | XXX |
| Gross Profit | -$8.9M | XXX | -$10.6M | XXX | XXX | XXX |
| Gross Margin | -73% | XXX | -94% | XXX | XXX | XXX |
| EBITDA | n/a | XXX | -$45.0M | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | -399% | XXX | XXX | XXX |
| EBIT | -$56.1M | XXX | -$56.7M | XXX | XXX | XXX |
| EBIT Margin | -457% | XXX | -503% | XXX | XXX | XXX |
| Net Profit | -$53.5M | XXX | -$53.5M | XXX | XXX | XXX |
| Net Margin | -436% | XXX | -474% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Nano X Imaging's stock price is $5.
Nano X Imaging has current market cap of $327M, and EV of $272M.
See Nano X Imaging trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $272M | $327M | XXX | XXX | XXX | XXX | $-0.86 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Nano X Imaging has market cap of $327M and EV of $272M.
Nano X Imaging's trades at 24.1x EV/Revenue multiple, and -6.0x EV/EBITDA.
Equity research analysts estimate Nano X Imaging's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Nano X Imaging has a P/E ratio of -6.1x.
See valuation multiples for Nano X Imaging and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $327M | XXX | $327M | XXX | XXX | XXX |
| EV (current) | $272M | XXX | $272M | XXX | XXX | XXX |
| EV/Revenue | 22.1x | XXX | 24.1x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | -6.0x | XXX | XXX | XXX |
| EV/EBIT | -4.8x | XXX | -4.8x | XXX | XXX | XXX |
| EV/Gross Profit | -30.4x | XXX | n/a | XXX | XXX | XXX |
| P/E | -6.1x | XXX | -6.1x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -6.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialNano X Imaging's last 12 month revenue growth is 80%
Nano X Imaging's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.3M for the same period.
Nano X Imaging's rule of 40 is -403% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Nano X Imaging's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Nano X Imaging and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 80% | XXX | 74% | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | -399% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | -403% | XXX | -318% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.3M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 15% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 179% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 409% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Nano X Imaging acquired XXX companies to date.
Last acquisition by Nano X Imaging was XXXXXXXX, XXXXX XXXXX XXXXXX . Nano X Imaging acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Nano X Imaging founded? | Nano X Imaging was founded in 2018. |
| Where is Nano X Imaging headquartered? | Nano X Imaging is headquartered in United States of America. |
| How many employees does Nano X Imaging have? | As of today, Nano X Imaging has 165 employees. |
| Who is the CEO of Nano X Imaging? | Nano X Imaging's CEO is Mr. Erez Meltzer. |
| Is Nano X Imaging publicy listed? | Yes, Nano X Imaging is a public company listed on NAS. |
| What is the stock symbol of Nano X Imaging? | Nano X Imaging trades under NNOX ticker. |
| When did Nano X Imaging go public? | Nano X Imaging went public in 2020. |
| Who are competitors of Nano X Imaging? | Similar companies to Nano X Imaging include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Nano X Imaging? | Nano X Imaging's current market cap is $327M |
| What is the current revenue of Nano X Imaging? | Nano X Imaging's last 12 months revenue is $12.3M. |
| What is the current revenue growth of Nano X Imaging? | Nano X Imaging revenue growth (NTM/LTM) is 80%. |
| What is the current EV/Revenue multiple of Nano X Imaging? | Current revenue multiple of Nano X Imaging is 22.1x. |
| Is Nano X Imaging profitable? | Yes, Nano X Imaging is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
